IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 50 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $137 | – | 390 | +20.4% | 0.00% | – |
| Q3 2022 | $0 | – | 324 | -8.5% | 0.00% | – |
| Q2 2022 | $0 | – | 354 | +8.9% | 0.00% | – |
| Q1 2022 | $0 | – | 325 | +0.3% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 324 | -75.5% | 0.00% | – |
| Q3 2021 | $1,000 | – | 1,323 | +347.0% | 0.00% | – |
| Q2 2021 | $0 | – | 296 | +17.5% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 252 | +19.4% | 0.00% | – |
| Q4 2020 | $1,000 | -66.7% | 211 | -85.8% | 0.00% | – |
| Q3 2020 | $3,000 | +50.0% | 1,483 | +1.4% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 1,463 | -22.9% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 1,897 | +47.7% | 0.00% | – |
| Q4 2019 | $2,000 | -50.0% | 1,284 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 1,284 | -41.4% | 0.00% | – |
| Q2 2019 | $5,000 | -80.0% | 2,191 | -77.4% | 0.00% | – |
| Q1 2019 | $25,000 | -7.4% | 9,689 | -0.3% | 0.00% | – |
| Q4 2018 | $27,000 | -69.3% | 9,716 | -0.7% | 0.00% | – |
| Q3 2018 | $88,000 | – | 9,786 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |